Добірка наукової літератури з теми "IgAN"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "IgAN".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "IgAN"
Zhang, Xue, Xinfang Xie, Sufang Shi, Lijun Liu, Jicheng Lv, and Hong Zhang. "Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis." Nephrology Dialysis Transplantation 35, no. 12 (August 3, 2019): 2117–23. http://dx.doi.org/10.1093/ndt/gfz151.
Повний текст джерелаKhairwa, Anju. "Indian scenario of IgA nephropathy: a systematic review and meta-analysis." African Health Sciences 21, no. 1 (April 16, 2021): 159–65. http://dx.doi.org/10.4314/ahs.v21i1.21.
Повний текст джерелаSuzuki, Hitoshi, Landino Allegri, Yusuke Suzuki, Stacy Hall, Zina Moldoveanu, Robert J. Wyatt, Jan Novak, and Bruce A. Julian. "Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?" Disease Markers 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7806438.
Повний текст джерелаIrabu, Hitoshi, Masaki Shimizu, Shuya Kaneko, Natsumi Inoue, Mao Mizuta, Kazuhide Ohta, and Akihiro Yachie. "Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy." Journal of Immunology Research 2020 (May 21, 2020): 1–10. http://dx.doi.org/10.1155/2020/4284379.
Повний текст джерелаLi, Guanhong, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, and Ruitong Gao. "Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy." Disease Markers 2019 (July 2, 2019): 1–11. http://dx.doi.org/10.1155/2019/9802839.
Повний текст джерелаKim, Jin Sug, Hyeon Seok Hwang, Sang Ho Lee, Yang Gyun Kim, Ju-Young Moon, Ji Yoon Kong, and Kyung Hwan Jeong. "Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy." Journal of Clinical Medicine 9, no. 11 (November 4, 2020): 3549. http://dx.doi.org/10.3390/jcm9113549.
Повний текст джерелаSanders, John T., M. Colleen Hastings, Zina Moldoveanu, Jan Novak, Bruce A. Julian, Zoran Bursac, and Robert J. Wyatt. "Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls." International Journal of Nephrology 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/8210641.
Повний текст джерелаFukao, Yusuke, Hitoshi Suzuki, Jin Sug Kim, Kyung Hwan Jeong, Yuko Makita, Toshiki Kano, Yoshihito Nihei, et al. "Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy." Journal of Clinical Medicine 11, no. 11 (June 2, 2022): 3173. http://dx.doi.org/10.3390/jcm11113173.
Повний текст джерелаCho, Won-Hee, Seon-Hwa Park, Seul-Ki Choi, Su Woong Jung, Kyung Hwan Jeong, Yang-Gyun Kim, Ju-Young Moon, et al. "Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease." Journal of Clinical Medicine 9, no. 8 (August 12, 2020): 2619. http://dx.doi.org/10.3390/jcm9082619.
Повний текст джерелаRizk, Dana V., Manish K. Saha, Stacy Hall, Lea Novak, Rhubell Brown, Zhi-Qiang Huang, Huma Fatima, Bruce A. Julian, and Jan Novak. "Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1." Journal of the American Society of Nephrology 30, no. 10 (August 23, 2019): 2017–26. http://dx.doi.org/10.1681/asn.2018111156.
Повний текст джерелаДисертації з теми "IgAN"
Mohey, Hesham. "Le risque rénal absolu (RRA) de dialyse ou décès chez les patients adultes avec néphropathie à IgA primaire (NIgA) : étude d'une cohorte prospective de néphropathie à IgA recrutée à Saint-Etienne (IGAN -STET-CO)." Phd thesis, Université Jean Monnet - Saint-Etienne, 2010. http://tel.archives-ouvertes.fr/tel-00675243.
Повний текст джерелаMohey, Hesham. "Le risque rénal absolu (RRA) de dialyse ou décès chez les patients adultes avec néphropathie à IgA primaire (NIgA) : étude d’une cohorte prospective de néphropathie à IgA recrutée à Saint-Etienne (IGAN -STET-CO)." Thesis, Saint-Etienne, 2010. http://www.theses.fr/2010STET010T/document.
Повний текст джерелаFor the individual patient with primary IgA nephropathy (IgAN), it remains a challenge to predict accurately the long term outcome at 10 and 20 years after disease onset. We studied it in a prospective cohort of 332 (237 males, 71.4%) biopsy-proven IgAN patients, the IGAN-STET-CO, aged at diagnosis of mean = 41.4 (SD=15.1) years, with a total exposure time of mean = 12.9 (9.5) y. Using three consensual risk factors (RF) simplified as dichotomous covariates : occurrence of hypertension, proteinuria ≥1 g/d, and severe pathological lesions (global optical score ≥8), we calculated an absolute renal risk (ARR) of dialysis/death (D/D), in analogy to the absolute cardiovascular risk. The ultimate prediction according to the number of RF present at diagnosis (ARR score: 0, 1, 2, or 3) was done by the Cox regression and the Kaplan-Meier survival methods. Overall, this ARR scoring permitted significant (P<0.0001) stratification of the risk. The cumulative incidence rate of D/D events (N=45), respectively at 10 and 20y, was 2 and 4% for ARR=0 (45.5% of all cases), 2 and 9% for ARR=1 (20.8%), 7 and 18% for ARR=2 (19.6%), and 29 and 64% for ARR=3 (N=47; 14.1%) in adequately treated patients. Effective control of hypertension and reduction of proteinuria improved survival without D/D when achieved. This absolute renal risk score evaluated at diagnosis, allowed accurate prediction of ultimate dialysis/death risk and was also validated in another cohort. This is a significant progress in the management of the individual patient with lgA nephropathy
Gomes, Michelle Marie. "Molecular characterization of IgA1-receptor interactions implicated in IgA nephropathy." University of Cincinnati / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1242938515.
Повний текст джерелаWehbe, Batoul. "IgA et rein : destructrice ou protectrice ? : Rôles de l'immunoglobuline A (IgA) dans deux pathologies rénales." Thesis, Limoges, 2018. http://www.theses.fr/2018LIMO0034/document.
Повний текст джерелаImmunoglobulin A (IgA) is the most synthetized immunoglobulin in mammals. IgA has ambivalent properties: it is implicated in the mechanisms of defense against pathogens but also in the immune tolerance of commensal microbiota. However, IgA can develop pathogenic properties. In the first part of my thesis, we studied the pathogenic effects of IgA. IgA deposits are the main characteristic of IgA nephropathy (IgAN). IgAN physiopathology is not yet clearly understood. The hypothesis of a glycosylation defect is strongly adapted. This defect can be due to IgA polymerization or antigenicity. It can also induce shedding of CD89 (IgA Fc receptor) or other factors. We studied the effect of variable region altered affinity, the light chain substitution and the association of IgA with CD89 on the development of kidney lesions and impairment of kidney function in four mouse models followed up during 12 months. In addition, we studied the physico-chemical properties of 28 IgA purified from patients with dysglobulinaemia and 28 chimeric IgA produced by hybridomas. The effect of these properties on the propensity of IgA for mesangial deposition was explored. In the second part, we studied the immunomodulatory and anti-inflammatory properties conferred by the overexpression of human IgA in a mouse model with systemic lupus (MRL/lpr model). In the last part, we contributed to the characterization of a transgenic mouse model producing IgA class 2 and to the study of the effect of IgA2-mediated signaling on B lymphocyte development. Altogether, obtained results show the pathogenic effect of low affinity-IgA on the development of IgA nephropathy. In addition, different analyses showed that molecular stability but not glycosylation profile is the determining factor for IgA deposition. On the other hand, IgA expression in lupus-prone mice extended their survival, delayed the onset of auto-immunity and ameliorated kidney functions in these animals which supports IgA anti-inflammatory properties. The study of IgA2-mediated signaling in the transgenic model showed the inhibitory effect of IgA2 on the early development of several B cell sub-populations. All of these results show the multiple effects of IgA which contribute on one hand to the pathogenesis of a complex disease (IgAN) and on the other hand to protection from autoimmunity, demonstrating the complexity of interactions and the regulatory character of this immunoglobulin
Günther, Ellen. "Examen igen?" Thesis, Södertörn University College, Lärarutbildningen, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:sh:diva-1999.
Повний текст джерелаThis paper will discuss the proposed reintroducing of a final degree in upper secondary school. In a public government inquiry that was released in March 2008 a proposal about reintroducing a final degree in upper secondary school was presented. A final degree has not been a part of the upper secondary school science 1968. Why was the system with a final degree abounded and why do the government want to reintroduce it?
Research in pedagogy has through the years presented numbers of theories about assessment. In last decades a great part of the discussion has been focused on formative assessment. In formative assessment the assessment is used as a pedagogy tool. The purpose is to help the student develop their learning process and to learn to work independently. The contrary to formative assessment is assessment which only purpose is to summarise and control the level of knowledge a student possesses.
The public government inquiry that led to abolish of a final degree in upper secondary school in 1968 shared many thoughts with theories about formative assessment. Forty years later the government has grown sick of all the formative assessment, which they think has led to a “muddled” school. The public government inquiry presented in 2008 wants to reintroduce a final degree and create a school where the student’s knowledge is orderly controlled and summarised.
Layward, Lorna. "IgA in IgA nephropathy." Thesis, University of Leicester, 1992. http://hdl.handle.net/2381/34129.
Повний текст джерелаAllen, Alice. "IgA glycosylation in IgA nephropathy." Thesis, University of Leicester, 1995. http://hdl.handle.net/2381/35028.
Повний текст джерелаMattsson, Madeleine, and Emma Liljefeldt. "MKB Vågade - igen?" Thesis, Malmö högskola, Fakulteten för kultur och samhälle (KS), 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-21945.
Повний текст джерелаWallin, Pérez Carolina. "Snurra min jord igen." Thesis, Kungl. Musikhögskolan, Institutionen för jazz, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:kmh:diva-105.
Повний текст джерелаMillet, Isabelle. "Récepteurs pour les IgA et propriétés biologiques des facteurs liant les IgA : iga-bf." Lyon 1, 1988. http://www.theses.fr/1988LYO1T156.
Повний текст джерелаКниги з теми "IgAN"
Igan to daichōgan. Tōkyō: Iwanami Shoten, 1999.
Знайти повний текст джерела(Japan), Tottori-ken. Igan shibō hangen taisaku ni kansuru hōkoku: Jushinritsu kōjō taisaku oyobi shūdan kenshin no kōka hantei. [Tottori-shi]: Tottori-ken, 1989.
Знайти повний текст джерелаŌtani, Katsuya. Pirorikin de wakatta i no atarashii byōkitachi: Ien kara igan made sono genʾin no nazo o toku. Tōkyō: Gendai Shorin, 2003.
Знайти повний текст джерелаIp e igŭn uri igŭn mal. Sŏul-si: Hakkojae, 2006.
Знайти повний текст джерелаEngqvist, Hans Erik. Ge igen! Stockholm: Bonniers junior förlag, 1985.
Знайти повний текст джерелаOnda, Riku. Shōsetsu igai. Tōkyō: Shinchōsha, 2005.
Знайти повний текст джерелаCulukiże, Nika. Igav-arakebi. Tʻbilisi: Gamomcʻemloba "Universali", 2008.
Знайти повний текст джерелаHizazi, Nasim. Simanta igal. Dhaka: Priti Prakashan, 1987.
Знайти повний текст джерелаIgav-arakebi. Tʻbilisi: Gamomcʻemloba "Universali", 2008.
Знайти повний текст джерелаDevelopment, Intergovernmental Authority on. IGAD strategy. Djibouti, Republic of Djibouti: IGAD Secretariat, 2005.
Знайти повний текст джерелаЧастини книг з теми "IgAN"
Gartler, Stanley M., R. Scott Hansen, Vinzenz Oji, Heiko Traupe, Julia Horn, Bodo Grimbacher, Srijita Sen-Chowdhry, et al. "IgAN." In Encyclopedia of Molecular Mechanisms of Disease, 1031. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_8940.
Повний текст джерелаNarita, Ichiei, Yoshikatsu Kaneko, Yumi Itoh, Yuichi Sakamaki, Seitaro Iguchi, Suguru Yamamoto, Minako Wakasugi, Junichiro J. Kazama, and Shin Goto. "Is IgA Nephropathy (IgAN) a Familial or Sporadic Disease?" In Pathogenesis and Treatment in IgA Nephropathy, 43–51. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55588-9_3.
Повний текст джерелаShah, Jui, and Maniklal Das. "IGAN: Intrusion Detection Using Anomaly-Based Generative Adversarial Network." In Advances in Intelligent Systems and Computing, 371–79. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2008-9_36.
Повний текст джерелаWold, Agnes E., Cecilia Motas, Catherina Svanborg, Lars Ake Hanson, and Jiri Mestecky. "Characterization of IgA1, IgA2 and Secretory IgA Carbohydrate Chains using Plant Lectins." In Advances in Experimental Medicine and Biology, 585–89. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1941-6_123.
Повний текст джерелаNovak, Jan, Kazuo Takahashi, Hitoshi Suzuki, Colin Reily, Tyler Stewart, Hiroyuki Ueda, Koshi Yamada, et al. "Heterogeneity of Aberrant O-Glycosylation of IgA1 in IgA Nephropathy." In Pathogenesis and Treatment in IgA Nephropathy, 53–68. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55588-9_4.
Повний текст джерелаSuzuki, Hitoshi, Zina Moldoveanu, Stacy Hall, Rhubell Brown, Bruce A. Julian, Robert J. Wyatt, Milan Tomana, Yasuhiko Tomino, Jan Novak, and Jiri Mestecky. "IgA Nephropathy: Characterization of IgG Antibodies Specific for Galactose-Deficient IgA1." In IgA Nephropathy Today, 129–33. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000102454.
Повний текст джерелаHiki, Yoshiyuki, Akihiko Ito, Yoshihiro Yamamoto, Koichiro Yamamoto, and Hitoo Iwase. "IgA Nephropathy and Aberrant Glycosylation of Tonsillar, Serum and Glomerular IgA1." In Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways, 68–70. Basel: KARGER, 2011. http://dx.doi.org/10.1159/000324609.
Повний текст джерелаClarkson, Anthony R. "IgA Nephropathy: History, Classification, and Geographic Distribution." In IgA Nephropathy, 1–8. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2039-5_1.
Повний текст джерелаAllardyce, Randall A. "The Biology of IgA Mucosal Immunity." In IgA Nephropathy, 127–56. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2039-5_10.
Повний текст джерелаEgido, Jesus. "The Role of Polymeric IgA in the Pathogenesis of IgA Nephropathy." In IgA Nephropathy, 157–75. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2039-5_11.
Повний текст джерелаТези доповідей конференцій з теми "IgAN"
Altun, Ilayda, Seha Saygılı, Nur Canpolat, Salim Çalışkan, and Lale Sever. "359 A novel COL4A4 mutation in the proband initially diagnosed as IgAN with autosomal recessive Alport syndrome." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.359.
Повний текст джерелаPaixão, Vitória da, Tamaris Roseira, Jônatas Bussador Do Amaral, Juliana De Melo Batista Dos Santos, and André Luis Lacerda Bachi. "IDOSOS SUPLEMENTADOS COM L-GLUTAMINA TEM MELHOR RESPOSTA DE MUCOSA E NÃO SÉRICA À VACINA PARA O VIRUS INFLUENZA." In II Congresso Brasileiro de Saúde On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/1448.
Повний текст джерелаSvärd, A., K. Roos Ljungberg, A. Kastbom, T. Skogh, and K. Martinsson. "AB0110 Serum and salivary iga1 and iga2 acpa subclasses in established rheumatoid arthritis and associations to smoking." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.4131.
Повний текст джерелаHitoo, Iwase, Nakamura Ikuko, Kenji Arai, Yoko Nagai, Kazunori Toma, Tadashi Katsumata, Takashi Sano, and Yutaka Kobayashi. "GENDER DIFFERENCE AND EPITOPE SPECIFICITY OF IGG ANTIBODY AGAINST IGA1 HINGE PORTION IN IGA NEPHROPATHY PATIENTS." In XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.666.
Повний текст джерелаQuiroz, Juan C., Amit Banerjee, and Sushil J. Louis. "IGAP." In the 10th annual conference. New York, New York, USA: ACM Press, 2008. http://dx.doi.org/10.1145/1389095.1389426.
Повний текст джерелаPedrosa, Lara Alípio, ARIANA LACERDA GARCIA, and BEATRIZ RIBEIRO COUTINHO DE MENDONÇA FURTADO. "OS BENEFÍCIOS DO ALEITAMENTO MATERNO NO SISTEMA IMUNOLÓGICO." In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/6018.
Повний текст джерелаLlorà, Xavier, Kumara Sastry, David E. Goldberg, Abhimanyu Gupta, and Lalitha Lakshmi. "Combating user fatigue in iGAs." In the 2005 conference. New York, New York, USA: ACM Press, 2005. http://dx.doi.org/10.1145/1068009.1068228.
Повний текст джерелаSzmurło, Agnieszka, Marek Wiewiórka, and Tomasz Gambin. "iGAP: Interactive Genomic Analysis Platform." In Photonics Applications in Astronomy, Communications, Industry, and High-Energy Physics Experiments 2018, edited by Ryszard S. Romaniuk and Maciej Linczuk. SPIE, 2018. http://dx.doi.org/10.1117/12.2502040.
Повний текст джерелаLlorà, Xavier, Noriko Imafuji Yasui, and David E. Goldberg. "Graph-theoretic measure for active iGAs." In the 10th annual conference. New York, New York, USA: ACM Press, 2008. http://dx.doi.org/10.1145/1389095.1389281.
Повний текст джерелаLI, WILFRED W., PETER W. ARZBERGER, CHANG LIM YEO, LARRY ANG, OSAMU TATEBE, SATOSHI SEKIGUCHI, KARPJOO JEONG, SUNTAE HWANG, SUSUMU DATE, and JAE-HYUCK KWAK. "PROTEOME ANALYSIS USING IGAP IN GFARM." In Proceedings of the 2nd International Life Science Grid Workshop, LSGRID 2005. WORLD SCIENTIFIC, 2006. http://dx.doi.org/10.1142/9789812772503_0013.
Повний текст джерелаЗвіти організацій з теми "IgAN"
Zachary, Wayne, Thomas Santarelli, Joan Ryder, and James Stokes. Developing a Multi-Tasking Cognitive Agent Using the COGNET/iGEN Integrative Architecture. Fort Belvoir, VA: Defense Technical Information Center, December 2000. http://dx.doi.org/10.21236/ada416891.
Повний текст джерелаIvy, John M. Production of Anti-Ferret IgA Antibodies; and production of monoclonal antibodies. Fort Belvoir, VA: Defense Technical Information Center, April 1994. http://dx.doi.org/10.21236/ada279534.
Повний текст джерелаSchmidt-Sane, Megan, Tabitha Hrynick, Erica Nelson, and Tom Barker. Mutual Learning for Policy Impact: Insights from CORE. Adapting research methods in the context of Covid-19. Institute of Development Studies (IDS), December 2021. http://dx.doi.org/10.19088/core.2021.008.
Повний текст джерелаKløcker Larsen, Rasmus, and Maria Boström. “Låt renen få igen landet som det var”: Konsekvenser av gruvan och vägen på Stihken för Vilhelmina Södra sameby. Stockholm Environment Institute, June 2021. http://dx.doi.org/10.51414/sei2021.007.
Повний текст джерелаHe, Mingyu, Tianying Chang, and Shoulin Zhang. Efficacy and safety of Tripterygium wilfordii glycosides in treatment of IgA nephropathy:A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0037.
Повний текст джерелаZachary, Wayne, Joan Ryder, James Stokes, Floyd Glenn, Jean-Christophe Le Mentec, and Thomas Santarelli. Developing Concept Learning Capabilities in the COGNET/IGEN Integrative architecture and Associated Agent-based Modeling and Behavioral Representation (AMBR) Air Traffic Control. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada439347.
Повний текст джерелаLumsden, Jessee. An Investigation of the Mechanism of IGA/SCC of Alloy 600 in Corrosion Accelerating Heated Crevice Environments. Technical Progress Report. Office of Scientific and Technical Information (OSTI), November 1999. http://dx.doi.org/10.2172/761827.
Повний текст джерелаLumsden, Jesse. An Investigation of the Mechanism of IGA/SCC of Alloy 500 in Corrosion Accelerating Heated Crevice Environments. Technical progress report. Office of Scientific and Technical Information (OSTI), March 2000. http://dx.doi.org/10.2172/762168.
Повний текст джерелаLumsden, Jesse. An Investigation of the Mechanism of IGA/SCC of Alloy 600 in Corrosion Accelerating Heated Crevice Environments. Technical Progress Report. Office of Scientific and Technical Information (OSTI), January 1999. http://dx.doi.org/10.2172/762745.
Повний текст джерелаLv, Guangxin, and Chengyuan Ming. Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0158.
Повний текст джерела